CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
November 2019
144
About the Report
About the Report
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
The Philippines healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The Philippines pharmaceutical market increased from ?128B in 2011 to ?176B in 2018 at a Compound Annual Growth Rate (CAGR) of 4.65%. In terms of US dollars, the pharmaceutical market was USD 2.96B in 2011, which increased to USD 3.34B in 2018 at a CAGR of 1.75%. The Philippines medical device market was valued at USD 196.18M in 2015, which increased to USD 227.10M in 2018. The Philippines pharmaceutical and medical device market is import-driven.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Unilab, Pfizer, GSK, Boehringer and Sanofi) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Fresenius Medical Care, Siemens Healthineers, and Philips Healthcare.)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Philippines
- Porter's five forces analysis for pharmaceutical and medical devices market of Philippines
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Philippines healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the Philippines healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Philippines healthcare market
Products
Products
Philippines, Pharmaceutical Market,Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape,Deals, Porter Five Forces,HealthTech Landscape, Opportunities and Challenges.
Table of Contents
Table of Contents
Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Events: Philippines Pharmaceutical History, 2005-2019
2.4 Key Events: Philippines Pharmaceutical Market
2.5 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, Philippines, 2018
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Major Therapeutic Areas
3.7 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Top Five Segments
4.3 Medical Device Market - Diagnostic Market
4.4 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Philippines
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Philippines
7 HealthTech Landscape
7.1 HealthTech Deals Landscape, Philippines
7.1.1 Key HealthTech Deals, Philippines
7.2 Adoption of Technology in Healthcare, Philippines
7.2.1 Key Developments: Technology in Healthcare, Philippines
7.3 HealthTech Landscape- Philippines- Benefits and Risks
8 Pharmaceutical and Medical Device Market - Porter's Five Forces Analysis
8.1 Pharmaceutical Market, Philippines - Porter's Five Forces Analysis
8.2 Medical Device Market, Philippines - Porter's Five Forces Analysis
9 Market Access
9.1 Overview of Healthcare System, Philippines
9.1.1 Department of Health, Philippines
9.2 Reimbursement of Medicinal Products, Philippines
9.3 Overview of Health Insurance, Philippines
9.3.1 Healthcare Spending and Health Price Index, Philippines
9.3.2 Pricing Policies, Philippines
9.4 Regulatory Landscape, Philippines
9.4.1 Overview of Regulatory Agencies
9.4.2 Market Authorization for Pharmaceutical Products, Philippines
9.4.3 Market Authorization for Medical Devices, Philippines
9.4.4 Intellectual Property Rights, Patent, Philippines
9.4.5 Intellectual Property Rights, Trademark, Philippines
9.4.6 Clinical Trial Regulations, Philippines
9.4.7 Pharmaceutical Establishment Regulation, Philippines
9.4.8 Exports and Imports, Philippines
9.4.9 Pharmaceutical Advertising Regulations, Philippines
9.4.10 Labeling and Packaging Regulations, Philippines
10 Country Healthcare Landscape
10.1 Healthcare Policy Highlights
10.2 Healthcare Facilities
10.3 Healthcare Parameters
10.4 Environmental Health
10.5 Healthcare Personnel
10.6 Disease Burden
10.7 Healthcare Expenditure
11 Trade Associations, Philippines
12 Trade Fairs, Philippines
13 Opportunities and Challenges
14 Appendix
14.1 Research Methodology
14.1.1 Coverage
14.1.2 Secondary Research
14.1.3 Forecasts
14.1.4 Expert Panel
14.2 Bibliography
14.3 Contact Us
List of Figure
List of Figures
Figure 1: Pharmaceutical Market, Philippines, Revenue (USD B), 2011-2018
Figure 2: Medical Device Market, Philippines, Revenue (USD M), 2015-2028
Figure 3: Healthcare Startups in Philippines, Philippines, 2019
Figure 4: Number of Deals (2018-2019)
Figure 5: 2018-2019 Deal Overview By Region
Figure 6: Country Profile, Philippines, 2019
Figure 7: Pharmaceutical Market, Philippines, Revenue (USD B), 2011-2018
Figure 8: Pharmaceutical Market, Philippines, Revenue Forecast (USD B), 2019-2025
Figure 9: Pharmaceutical Market, Philippines, Pharmaceutical Exports, 2011-2018
Figure 10: Pharmaceutical Market, Philippines, Top Export Partners, 2018
Figure 11: Pharmaceutical Market, Philippines, Pharmaceutical Imports, 2011-2018
Figure 12: Pharmaceutical Market, Philippines, Top Import Partners, 2018
Figure 13: Utilization of Pharmaceutical Products by Value over Time (%), Philippines, 2010-2014
Figure 14: List of Reference Biotherapeutic Products, Philippines
Figure 15: Pharmaceutical OTC Market, Philippines, Revenue (USD B), 2011-2018
Figure 16: Major Self-Medication Product Groups (Revenue, USD M), Philippines, 2017
Figure 17: Pharmaceutical Market, Supply Chain, Philippines
Figure 18: Major Therapeutic Area by Pharmaceutical Sales (%), Philippines
Figure 19: Medical Device Market, Philippines, Revenue (USD M), 2015-2018
Figure 20: Medical Device Market, Philippines, Revenue by Segment (USD M), 2018
Figure 21: Medical Device Market, Philippines, Revenue (USD B) of Major Companies, 2018
Figure 22: Deal Value and Deal Count, Pharmaceutical Market, Philippines, 2018-2019
Figure 23: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Philippines, 2018-2019
Figure 24: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Philippines, 2018-2019
Figure 25: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Philippines, 2018-2019
Figure 26: Deal Value, HealthTech, Philippines, 2018-2019
Figure 27: Deal Count, HealthTech, Philippines, 2018-2019
Figure 28: National eHealth Capacity Roadmap, Philippines
Figure 29: Overview of Healthcare System, Philippines, 2019
Figure 30: Department of Health, Philippines, 2019
Figure 31: Classification into Core and Complementary Medicines, Philippines
Figure 32: Selection of Medicines for Inclusion in the PNF, Philippines
Figure 33: NHIP Members Covered by Sector, 2018
Figure 34: OOP Expenditure (% of total expenditure on health), Philippines, 2011-2016
Figure 35: Annual Rate of Change (%), Health Price Index, Philippines, 2011-2017
Figure 36: Price Regulation, Philippines, 2019
Figure 37: Philippines FDA, Organizational Structure, Philippines, 2019
Figure 38: Drug Registration Process, Philippines, 2019
Figure 39: New Drug Registration Requirements, Philippines, 2019
Figure 40: Generic Drug Registration Requirements, Philippines, 2019
Figure 41: Technical Requirements for Authorization of Medical Devices, Philippines, 2019
Figure 42: Authorization of Medical Devices, Philippines, 2019
Figure 43: Patent Approval Process, Philippines, 2019
Figure 44: Trademark Approval Process, Philippines, 2019
Figure 45: Pharmaceutical Clinical Trials Count By Trial Status, Philippines, 2018-2019
Figure 46: Pharmaceutical Clinical Trials Count By Phase, Philippines, 2018-2019
Figure 47: Pharmaceutical Clinical Trials Count By Therapy Area, Philippines, 2018-2019
Figure 48: Top Five Pharmaceutical Clinical Trials Sponsor By Count, Philippines, 2018-2019
Figure 49: Medical Devices Clinical Trials Count By Therapy Area, Philippines, 2018-2019
Figure 50: Medical Devices Clinical Trials Count By Trial Status, Philippines, 2018-2019
Figure 51: Clinical Trial Approval Process, Philippines, 2019
Figure 52: License to Operate, Philippines, 2019
Figure 53: Export Procedure, Philippines, 2019
Figure 54: Import Procedure, Philippines, 2019
Figure 55: Number of Hospitals, Philippines, 2011-2015
Figure 56: Diagnostic Equipment (per million population), Philippines, 2010-2013
Figure 57: Government Hospital Beds, Philippines
Figure 58: Government Hospital Beds, Philippines
Figure 59: Hospital Beds (per 10,000 population), Philippines
Figure 60: Life Expectancy, 2011-2017, Philippines
List of Table
List of Tables
Table 1: Major Self-Medication Product Groups (Revenue, USD M), Philippines, 2017
Table 2: Major Therapeutic Area by Pharmaceutical Sales (%), Philippines
Table 3: Medical Device Market, Philippines, Revenue by Segment, 2018
Table 4: Premium Contributions, Philippines, 2019-2025
Table 5: Benefit Payment, Philippines, 2018
Table 6: Private Insurance Providers, Philippines, 2018
Table 7: Regulatory Fees and Charges for Pharmaceutical Products, Philippines, 2019
Table 8: Classification of Medical Devices, Philippines, 2019
Table 9: Regulatory Fees and Charges for Medical Devices, Philippines, 2019
Table 10: Patent Fees, Philippines, 2019
Table 11: Patent Maintenance Fees, Philippines, 2019
Table 12: Trademark Fees, Philippines, 2019
Table 13: Trademark Maintenance Fees, Philippines, 2019
Table 14: Fees for LTO, Philippines, 2019
Table 15: Label of a Pharmaceutical Product, Philippines
Table 16: Minimum Particulars to Appear on Blisters or Strips
Table 17: Minimum Particulars to Appear on Primary Label of Small Containers
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.